SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-043402
Filing Date
2021-03-30
Accepted
2021-03-29 17:36:17
Documents
4
Period of Report
2021-03-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2111241d1_8k.htm 8-K 25092
2 EXHIBIT 99.1 tm2111241d1_ex99-1.htm EX-99.1 474849
3 EXHIBIT 99.2 tm2111241d1_ex99-2.htm EX-99.2 70553
4 GRAPHIC tm2111241d1_ex99-2img01.jpg GRAPHIC 4340
  Complete submission text file 0001104659-21-043402.txt   577840
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 21782800
SIC: 2834 Pharmaceutical Preparations